Plasmid DNA Manufacturing Markets, 2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Plasmid DNA Manufacturing Market by Scale of Operation, Application Area, Therapeutic Area, and Geography: Industry... Read more.
Travelers Reports Third Quarter 2023 Net Income of $404 million and Core Income of $454 million
Third Quarter 2023 Net Income per Diluted Share of $1.74 and Return on Equity of 7.7% Third Quarter 2023 Core Income per Diluted Share of $1.95 and Core Return on... Read more.
Dollar General Extends American Red Cross Partnership
Company Continues Support of Disaster Responder Program to Aid in Relief and Recovery Efforts GOODLETTSVILLE, Tenn.–(BUSINESS WIRE)–Today, Dollar General... Read more.
AECOM awarded contract to serve as technical advisor for Hamilton LRT in Ontario, Canada
DALLAS–(BUSINESS WIRE)–AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced that it has been appointed by Metrolinx... Read more.
Ferguson Share Repurchase Program – Weekly Report
WOKINGHAM, England–(BUSINESS WIRE)–Ferguson plc (NYSE: FERG, LSE: FERG) (the “Company”) announces today that it purchased a total of 68,300 of its... Read more.
U.S. Bancorp Reports Third Quarter 2023 Results
MINNEAPOLIS–(BUSINESS WIRE)–U.S. Bancorp reported its third quarter 2023 results today. The earnings release, business line schedules and slide presentation... Read more.
Kolibri Global Energy Inc. Announces Addition to Board of Directors
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Kolibri Global Energy Inc. (the “Company” or “Kolibri“) (TSX: KEI, NASDAQ: KGEI) is pleased... Read more.
Sage Therapeutics Announces U.S. Food and Drug Administration Granted SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain... Read more.
Allen Fozzard Joins Stone-Goff Partners as Head of Business Development
BOSTON & NEW YORK–(BUSINESS WIRE)–Stone-Goff Partners, a growth-oriented private equity firm focused on technology-driven B2B service companies,... Read more.
Global Allergy Diagnostics Strategic Market Report 2023: Market to Reach $8.3 Billion by 2030 – Increasing Cases of Allergies Drive Development of Advanced Allergy Diagnostics Solutions – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergy Diagnostics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s... Read more.